23-valent Pneumococcal PolysaccharideVaccine

23-valent Pneumococcal PolysaccharideVaccine
Product Description

Covers a wider range of pneumococcal serotypesMore economical for low-and middle-income countries
Patented process
Great immunogenicity and safety
Prefilled Syringe

Chongqing Zhifei Biological Products Co., Ltd.

  • CN
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Manufacturer/Innovator

Chongqing Zhifei Biological Products Co., Ltd.

  • CN
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Manufacturer/Innovator

More Products from Chongqing Zhifei Biological Products Co., Ltd. (4)

  • Recombinant Mycobacterium Tuberculosis Fusion Protein

    Product Recombinant Mycobacterium Tuberculosis Fusion Protein

    C-TST is a new diagnose method to detect Mtb infectionfor,which uses antigen-specific (ESAT6 & CFP10) immune response, same with the principle of action used in IGRAs.(1)Suitable for Large Scale LTBI Screening; 
    (2)Non Cross-React with BCG Vaccine; 
    (3)WHO Guideline Recommended;  q...
  • semaglutide

    Product semaglutide

    we can supply the semaglutide API with a good price and good quality,we are also open for the cooperation model.
  • Meningococcal Polysaccharide Vaccine

    Product Meningococcal Polysaccharide Vaccine

    Chongqing zhifei biological products co., ltd offers a wide range of products which includes meningococcal polysaccharide vaccine. Function and use: it can be used to prevent epidemic cerebrospinal meningitis caused by meningococcus group a, c, y, and w135 infection. Contact us for more information.
  • Group A, C Meningococcal Polysaccharide-Conjugate Vaccine

    Product Group A, C Meningococcal Polysaccharide-Conjugate Vaccine

    MeningACon is the first approved product in China,more than 36 million doses has been used.

Chongqing Zhifei Biological Products Co., Ltd. resources (1)